New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

By A Mystery Man Writer

Mechanisms of SARS-CoV-2 entry into cells

Browse Articles Cellular & Molecular Immunology

Aptamer-Mediated Antiviral Approaches for SARS-CoV-2

Protein-based COVID-19 vaccines could be game-changing - Boston Children's Answers

Immune Network

Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review of the experimental studies

Current advances in the development of SARS-CoV-2 vaccines

The SARS CoV-2 spike domain, RGD and integrin binding effect-relationship for vaccine design strategy

How studies of coronavirus immunity can inform better vaccines, treatments

Dealing with a mucosal viral pandemic: lessons from COVID-19 vaccines - Mucosal Immunology

Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach - AJMB: Volume 14, Issue 1, Year 2022 - AJMB

SARS-CoV-2 and its impact on the cardiovascular and digestive

©2016-2024, doctommy.com, Inc. or its affiliates